Q vectors, bicistronic retroviral vectors for gene transfer

BioTechniques

Volumn 28, Issue 4, 2000, Pages 702-708

  Julius, Martin A ^a   Yan, Qingyou ^a   Zheng, Zhili ^a   Kitajewski, Jan ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ARTICLE; CISTRON; GENE EXPRESSION; GENE TRANSFER; LONG TERMINAL REPEAT; MOLONEY MURINE SARCOMA ONCOVIRUS; NONHUMAN; VIRUS REPLICATION;

ANIMALIA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; DNA VIRUSES; MOLONEY MURINE SARCOMA VIRUS; MOUSE SARCOMA VIRUS; MURINAE; MURINE SARCOMA ONCOVIRUS; ONCOVIRINAE;

EID: 0034036146     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/00284st06     Document Type: Article

References (28)

1. Adam, M.A., N. Ramesh, A.D. Miller and W.R. Osborne. 1991. Internal initiation of translation in retroviral vectors carrying picornavirus 5′ nontranslated regions. J. Virol. 65:4985-4990.
2. Bender, M.A., T.D. Palmer, R.E. Gelinas and A.D. Miller. 1987. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J. Virol. 61:1639-1646.
3. Boris-Lawrie, K.A. and H.M. Temin. 1993. Recent advances in retrovirus vector technology. Curr. Opin. Genet. Dev. 3:102-109.
4. Boshart, M., F. Weber, G. Jahn, K. Dorsch-Hasler, B. Fleckenstein and W. Schaffner. 1985. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell. 41:521-530.
5. Brown, A.M.C. and J.P. Dougherty. 1995. Retroviral vectors, p. 113-142. In D.M. Glover and B.D. Hames (Eds.), DNA Cloning IV, Mammalian Systems-A Practical Approach, vol. 4. Oxford University Press, Oxford.
6. Crystal, R.G. 1995. Transfer of genes to humans: early lessons and obstacles to success. Science. 270:404-410.
7. Danos, O. and R.C. Mulligan. 1988. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. USA. 85:6460-6464.
8. Emerman, M. and H.M. Temin. 1984. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell. 59:449-467.
9. Finer, M.H., T.J. Dull, L. Qin, D. Farson and M.R. Roberts. 1994. kat: a high-efficiency retroviral transduction system for primary human T lymphocytes. Blood. 83:43-50.
10. Geballe, A.P., R.R. Spaete and E.S. Mocarski. 1986. A cis-acting element within the 5′ leader of a CMV b transcript determines kinetic class. Cell. 40:865-872.
11. Ghattas, I.R., J.R. Sanes and J.E. Majors. 1991. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol. Cell Biol. 11:5848-5859.
12. Jasin, M. and P. Zalamea. 1992. Analysis of Escherichia coli beta-galactosidase expression in transgenic mice by flow cytometry of sperm. Proc. Natl. Acad. Sci USA. 89:10681-10685.
13. Kinsella, T.M. and G.P. Nolan. 1996. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Human Gene Ther. 7:1405-1413.
14. Kownin, P. and H.L. Robinson. 1990. Murine retroviral vectors: T-cell line specific expression of a cytomegalovirus immediate early promoter. BioTechniques 8:501-502.
15. Lauret, E., I. Riviere, V. Rousseau, V. Vieillard, J. De Maeyer-Guignard and E. De Maeyer. 1993. Development of methods for somatic cell gene therapy directed against viral diseases, using retroviral vectors carrying the murine or human interferon-beta coding sequence: establishment of the antiviral state in human cells. Human Gene Ther. 4:567-577.
16. Lynch, C.M., D.I. Israel, R.J. Kaufman and A.D. Miller. 1993. Sequences in the coding region of clotting factor VIII act as dominant inhibitors of RNA accumulation and protein production. Human Gene Ther. 4:259-272.
17. Miller, A.D., M.A. Bender, E.A. Harris, M. Kaleko and R.E. Gelinas. 1988. Design of retrovirus vectors for transfer and expression of the human beta-globin gene. J. Virol. 62:4337-4345.
18. Miller, A.D. and G.J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980-990.
19. Naviaux, R.K., E. Costanzi, M. Haas and I.M. Verma. 1996. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol. 70:5701-5705.
20. Olsen, J.C. and J. Sechelski. 1995. Use of sodium butyrate to enhance production of retroviral vectors expressing CFTR cDNA. Human Gene Ther. 6:1195-1202.
21. Ory, D.S., B.A. Neugeboren and R.C. Mulligan. 1996. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudo-types. Proc. Natl. Acad. Sci. USA. 93:11400-11406.
22. Pear, W.S., G.P. Nolan, M.L. Scott and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA. 90:8392-8396.
23. Shimizu, H., M.A. Julius, M. Giarre, Z. Zheng, A.M.C. Brown and J. Kitajewski. 1997. Transformation by Wnt family proteins correlates with regulation of b-catenin. Cell Growth Differ. 8:1349-1358.
24. Soneoka, Y., P.M. Cannon, E.E. Ramsdale, J.C. Griffiths, G. Romano, S.M. Kingsman and A.J. Kingsman. 1995. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 25:628-633.
25. Vaidya, A.B., E.Y. Lasfargues, J.B. Sheffield and W.G. Coutinho. 1978. Murine mammary tumor virus (MMuTV) infection of an epithelial cell line established from C57BL/6 mouse mammary glands. Virology. 90:12-22.
26. Varmus, H. 1988. Retroviruses. Science. 240:1427-1435.
27. Yang, S., R. Delgado, S.R. King, C. Woffendin, C.S. Barker, Z.Y. Yang, L. Xu, G.P. Nolan and G.J. Nabel. 1999. Generation of retroviral vector for clinical studies using transient transfection. Human Gene Ther. 10:123-132.
28. Yu, S.F., T. von Ruden, P.W. Kantoff, C. Garber, M. Seiberg, U. Ruther, W.F. Anderson, E.F. Wagner and E. Gilboa. 1986. Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc. Natl. Acad. Sci. USA. 83:3194-3198.